These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 23861325

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
    Bektemür G, Ozer F, Kanat F, Imecik O.
    Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
    [Abstract] [Full Text] [Related]

  • 23. Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival.
    Lan CC, Wu YK, Lee CH, Huang YC, Huang CY, Tsai YH, Huang SF, Tsao TC.
    Jpn J Clin Oncol; 2010 Mar; 40(3):234-40. PubMed ID: 19933689
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.
    Fiorelli A, Ricci S, Feola A, Mazzella A, D'Angelo L, Santini M, Di Domenico M, Di Carlo A.
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):411-8. PubMed ID: 26769731
    [Abstract] [Full Text] [Related]

  • 26. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
    Wang M, Zhang Z, Wang X.
    Clinics (Sao Paulo); 2014 Apr; 69(12):799-803. PubMed ID: 25627990
    [Abstract] [Full Text] [Related]

  • 27. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng QH.
    Clin Chim Acta; 2013 Jun 05; 421():230-5. PubMed ID: 23523589
    [Abstract] [Full Text] [Related]

  • 28. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
    Ozsu S, Abul Y, Mentese A, Bektas H, Uzun A, Ozlu T, Porcel JM.
    Respirology; 2013 May 05; 18(4):657-62. PubMed ID: 23286371
    [Abstract] [Full Text] [Related]

  • 29. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
    Lv M, Cha N, Zou YF, Leng JH, Hao YY, Wang S.
    Diagn Cytopathol; 2021 Jul 05; 49(7):811-816. PubMed ID: 33818924
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
    Wang LX, Chen WX, Wu J, Chen SX, Huang XY, Chen YF.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec 05; 29(12):804-7. PubMed ID: 17327081
    [Abstract] [Full Text] [Related]

  • 32. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
    Lam CW, Law CY.
    J Proteome Res; 2014 Sep 05; 13(9):4040-6. PubMed ID: 25117182
    [Abstract] [Full Text] [Related]

  • 33. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
    Shu J, Sun G, Liu H, Liu J.
    Acta Oncol; 2007 Sep 05; 46(7):1004-11. PubMed ID: 17917830
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.
    Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, Liu B.
    Int J Cancer; 2009 Oct 15; 125(8):1921-5. PubMed ID: 19585499
    [Abstract] [Full Text] [Related]

  • 36. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C, Porfiridis I, Psallidas I, Kollintza A, Stathopoulos GT, Papiris SA, Roussos C, Kalomenidis I.
    Respirology; 2009 Jul 15; 14(5):716-22. PubMed ID: 19476604
    [Abstract] [Full Text] [Related]

  • 37. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?
    Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB, Herman JG.
    Ann Thorac Surg; 2005 Oct 15; 80(4):1241-7. PubMed ID: 16181847
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z, Li H, Zhu H, Bai C.
    Med Oncol; 2015 Jan 15; 32(1):312. PubMed ID: 25491139
    [Abstract] [Full Text] [Related]

  • 40. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP, Hu CP, Yang HZ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec 15; 28(6):608-10. PubMed ID: 15804072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.